Zobrazeno 1 - 10
of 15
pro vyhledávání: '"David D. Dow"'
Autor:
Jason S. Link, Debra L. Palka, Jack Green, William J. Overholtz, Carolyn A. Griswold, Laurel A. Col, Joseph J. Vitaliano, Kevin D. Friedland, Michael J. Fogarty, Vincent G. Guida, John E. O'Reilly, Christopher M. Legault, David D. Dow
Publikováno v:
Ecological Modelling. 220:351-369
Exploring the response of an ecosystem, and subsequent tradeoffs among its biological community, to human perturbations remains a key challenge for the implementation of an ecosystem approaches to fisheries (EAF). To address this and related issues,
Autor:
John E. O'Reilly, Jack Green, Lisa Methratta, William J. Overholtz, Jason S. Link, Laurel A. Col, Michael J. Fogarty, Joseph J. Vitaliano, Carolyn A. Griswold, Jon Brodziak, Debra L. Palka, David D. Dow, Vincent G. Guida, William T. Stockhausen, Christopher M. Legault
Publikováno v:
Journal of Marine Systems. 74:453-474
During the past half-century notable changes have occurred in the Northeast U.S. (NEUS) Continental Shelf Large Marine Ecosystem (LME). To understand how the system functions as a whole, to evaluate the potential responses of this ecosystem to numero
Autor:
Jason S. Link, Joseph J. Vitaliano, Jon Brodziak, Vincent G. Guida, William T. Stockhausen, Christopher M. Legault, William J. Overholtz, Debra L. Palka, David D. Dow, E Methratta, Jack Green, Michael J. Fogarty, John E. O'Reilly
Publikováno v:
Journal of Northwest Atlantic Fishery Science. 39:83-101
We developed a mass balance ecosystem network model for Georges Bank, a highly productive and intensively studied marine system located off the New England coast. This effort is part of a broader initiative, the Energy Modeling and Analysis eXercise
Autor:
Karen B. Bartlett, Robert C. Harriss, Ramona Pelletier-Travis, David P. Brannon, Daniel I. Sebacher, Jean M. Hartman, David S. Bartlett, David D. Dow
Publikováno v:
Global Biogeochemical Cycles. 3:363-374
Natural wetlands are presumed to be major sources of atmospheric methane, but current estimates of the global wetland emission vary by almost a factor of 20. Estimates of global source strengths are based on extrapolation of in situ flux measurements
Autor:
Blair RA; Department of Political Science and Watson Institute for International and Public Affairs, Brown University, United States. Electronic address: robert.blair@brown.edu., Curtice T; Department of Politics and Center for Public Policy, Drexel University, United States. Electronic address: tbc52@drexel.edu., Dow D; School of Government and Public Policy, University of Arizona, United States. Electronic address: ddow@arizona.edu., Grossman G; Department of Political Science, University of Pennsylvania, United States. Electronic address: ggros@upenn.edu.
Publikováno v:
Social science & medicine (1982) [Soc Sci Med] 2022 Jul; Vol. 305, pp. 115045. Date of Electronic Publication: 2022 May 21.
Autor:
O'Dowd DP; Sports Orthopaedic Fellow - Unisports Sports Medicine, Auckland, New Zealand., Dow D; Consultant Radiologist, Auckland Radiology Group, Auckland, New Zealand., Rosenfeldt MP; Consultant Orthopaedic Surgeon - Unisports Sports Medicine, Auckland, New Zealand.
Publikováno v:
The New Zealand medical journal [N Z Med J] 2021 Apr 16; Vol. 134 (1533), pp. 110-114. Date of Electronic Publication: 2021 Apr 16.
Autor:
Hughes P; Department of Radiology, Auckland City Hospital, Auckland, New Zealand., Dow D; Department of Radiology, Auckland City Hospital, Auckland, New Zealand., Boyer L; Department of Radiology, Auckland City Hospital, Auckland, New Zealand., Morganti V; Department of Radiology, Auckland City Hospital, Auckland, New Zealand.
Publikováno v:
Journal of medical imaging and radiation oncology [J Med Imaging Radiat Oncol] 2019 Aug; Vol. 63 (4), pp. 479-480. Date of Electronic Publication: 2019 Mar 14.
Autor:
Picco G; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Chen ED; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Alonso LG; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Behan FM; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Gonçalves E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Bignell G; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Matchan A; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Fu B; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Banerjee R; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Anderson E; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Butler A; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Benes CH; Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA., McDermott U; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK.; AstraZeneca, CRUK Cambridge Institute, Cambridge, CB2 0RE, UK., Dow D; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK.; Research and Development, GlaxoSmithKline, Stevenage, SG1 2NY, UK.; Research and Development, GlaxoSmithKline, Collegeville, PA, 19426-0989, USA., Iorio F; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Stronach E; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK.; Research and Development, GlaxoSmithKline, Stevenage, SG1 2NY, UK.; Research and Development, GlaxoSmithKline, Collegeville, PA, 19426-0989, USA., Yang F; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Yusa K; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Saez-Rodriguez J; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge, CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK.; Institute for Computational Biomedicine, Faculty of Medicine, Bioquant, Heidelberg University, 69120, Heidelberg, Germany., Garnett MJ; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, CB10 1SA, UK. mathew.garnett@sanger.ac.uk.; Open Targets, Wellcome Genome Campus, Cambridge, CB10 1SA, UK. mathew.garnett@sanger.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2019 May 16; Vol. 10 (1), pp. 2198. Date of Electronic Publication: 2019 May 16.
Autor:
Behan FM; Wellcome Sanger Institute, Cambridge, UK.; Open Targets, Cambridge, UK., Iorio F; Wellcome Sanger Institute, Cambridge, UK.; Open Targets, Cambridge, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK., Picco G; Wellcome Sanger Institute, Cambridge, UK., Gonçalves E; Wellcome Sanger Institute, Cambridge, UK., Beaver CM; Wellcome Sanger Institute, Cambridge, UK., Migliardi G; Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Santos R; GlaxoSmithKline Research and Development, Stevenage, UK., Rao Y; GlaxoSmithKline Research and Development, Collegeville, PA, USA., Sassi F; Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy., Pinnelli M; Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Ansari R; Wellcome Sanger Institute, Cambridge, UK., Harper S; Wellcome Sanger Institute, Cambridge, UK., Jackson DA; Wellcome Sanger Institute, Cambridge, UK., McRae R; Wellcome Sanger Institute, Cambridge, UK., Pooley R; Wellcome Sanger Institute, Cambridge, UK., Wilkinson P; Wellcome Sanger Institute, Cambridge, UK., van der Meer D; Wellcome Sanger Institute, Cambridge, UK., Dow D; Open Targets, Cambridge, UK.; GlaxoSmithKline Research and Development, Stevenage, UK., Buser-Doepner C; Open Targets, Cambridge, UK.; GlaxoSmithKline Research and Development, Collegeville, PA, USA., Bertotti A; Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Trusolino L; Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy.; Department of Oncology, University of Torino, Turin, Italy., Stronach EA; Open Targets, Cambridge, UK.; GlaxoSmithKline Research and Development, Stevenage, UK., Saez-Rodriguez J; Open Targets, Cambridge, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK.; Faculty of Medicine, Joint Research Centre for Computational Biomedicine, RWTH Aachen University, Aachen, Germany.; Institute for Computational Biomedicine, Heidelberg University, Faculty of Medicine, Bioquant, Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany., Yusa K; Wellcome Sanger Institute, Cambridge, UK. k.yusa@infront.kyoto-u.ac.jp.; Open Targets, Cambridge, UK. k.yusa@infront.kyoto-u.ac.jp.; Stem Cell Genetics, Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, Japan. k.yusa@infront.kyoto-u.ac.jp., Garnett MJ; Wellcome Sanger Institute, Cambridge, UK. mathew.garnett@sanger.ac.uk.; Open Targets, Cambridge, UK. mathew.garnett@sanger.ac.uk.
Publikováno v:
Nature [Nature] 2019 Apr; Vol. 568 (7753), pp. 511-516. Date of Electronic Publication: 2019 Apr 10.
Autor:
Dow D; Department of Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio., Molleran V; Department of Radiology, University of Cincinnati Medical Center, Cincinnati, Ohio.
Publikováno v:
The breast journal [Breast J] 2016 Jan-Feb; Vol. 22 (1), pp. 118-20. Date of Electronic Publication: 2015 Nov 20.